Naloxone: ineffective in improving cardiac performance after hypoperfusion in swine.
A study was done to measure beta-endorphin immunoreactivity (beta-EI) in swine subjected to cardiopulmonary bypass at normal aortic perfusion pressures and during low-flow states such as can occur with shock. Fifteen pigs, divided into three groups of five each, were placed on total and right heart bypass and perfused as follows: group I, normal blood pressure (80 mmHg); group II, low blood pressure (45 mmHg); and group III, low flows (25 ml/kg/hr). beta-endorphin immunoreactivity was assayed six times during the procedure. Ventricular performance was evaluated by measuring stroke volume (SV) while controlling preload, afterload, and heart rate. Determinations of SV were made at the beginning of bypass, after a 1-hr pump run, and after administration of naloxone (1.1 mg/kg). There were no significant changes in beta-EI in any of the groups during the study. The initial SV in group III (23 +/- 6 ml) decreased significantly (p less than 0.05) after 1 hr of decreased cardiac perfusion (8.0 +/- 7 ml) and was not improved by naloxone (5.0 +/- 7 ml). Ventricular performance was not improved in any group following naloxone administration. In our study, naloxone administered to swine following inadequate myocardial perfusion did not effect a significant cardiac hemodynamic response.
Heydorn
W H
WH
Moores
W Y
WY
Bellamy
R F
RF
O'Benar
J D
JD
D000818:Animals; D002315:Cardiopulmonary Bypass; D003326:Coronary Circulation / Q000187:drug effects; D004723:Endorphins / Q000097:blood; D006439:Hemodynamics / Q000187:drug effects*; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D009270:Naloxone / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D012769:Shock / Q000188:drug therapy* / Q000503:physiopathology; D013318:Stroke Volume / Q000187:drug effects; D013552:Swine; D001615:beta-Endorphin
D004723:Endorphins; D007773:Lactates; D019344:Lactic Acid; D009270:Naloxone; D001615:beta-Endorphin